- Can AI do scientific research?; The 'magic bullet' search has faded in immunotherapy; and moreWelcome back to Endpoints Weekly! We’ve got a team of reporters on the ground in Chicago this weekend for ASCO, including my fellow Weekly co-author Max Gelman. If you haven’t already, check out Ma…Endpoints · 1mo ago↗ source
- At ASCO, Merck makes case for a ‘cornerstone’ cancer drug<p>Study results accrued so far are giving Merck greater conviction that the therapy, licensed from a China-based biotech, was worth placing into a sprawling Phase 3 program.</p>BioPharma Dive · 1mo ago↗ source
- Bristol Myers unveils data for one of its next-gen blood cancer drugs<figure><div><img src="https://imgproxy.divecdn.com/aUhcesS0eCO3NThNNqPfIC_gM2-0lSalzL7WEg-RP7g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02ODA4MDQ3ODAuanBn.…